Clinical Trials - May 7, 2024
The pioneering STEM-PD clinical trial has advanced to higher dose testing
After a positive initial safety evaluation, the pioneering STEM-PD (stem cell-based transplant for Parkinson’s disease) clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived from stem cells. A […]
Clinical Trials - March 26, 2024
Sobi announces positive Phase 3 results
Sobi has announced results from the AVA-PED-301 study, evaluating the efficacy and safety of avatrombopag (Doptelet) for the treatment of paediatric patients with immune thrombocytopenia (ITP) of at least 6 months’ duration. The study enrolled 75 subjects between 1 and <18 years and the primary endpoint, durable platelet response, was met in 28% of avatrombopag […]